Indies Pharma Jamaica Limited
JMSE:INDIES 株式レポート
Indies Pharma Jamaica マネジメント 主要情報 CEO給与比率 n/a CEO在任期間 no data CEOの所有権 n/a 経営陣の平均在職期間 データなし 取締役会の平均在任期間 4.1yrs
経営陣の近況
Indies Pharma Jamaica Limited, Annual General Meeting, May 29, 2024 May 15
Insufficient new directors Nov 01
Indies Pharma Jamaica Limited Announces Appointment of Directors Oct 18
すべての更新を表示
Third quarter 2024 earnings released: EPS: JA$0.03 (vs JA$0.06 in 3Q 2023) Sep 15
Investor sentiment improves as stock rises 21% Aug 01
Second quarter 2024 earnings released: EPS: JA$0.053 (vs JA$0.02 in 2Q 2023) Jun 20
New minor risk - Share price stability Jun 14
Investor sentiment improves as stock rises 17% Jun 01
Indies Pharma Jamaica Limited, Annual General Meeting, May 29, 2024 May 15
First quarter 2024 earnings released: EPS: JA$0.047 (vs JA$0.044 in 1Q 2023) Mar 15
Full year 2023 earnings released: EPS: JA$0.16 (vs JA$0.17 in FY 2022) Feb 06
Full year 2023 earnings released: EPS: JA$0.16 (vs JA$0.17 in FY 2022) Dec 16
Investor sentiment deteriorates as stock falls 16% Dec 05
Insufficient new directors Nov 01
Third quarter 2023 earnings released: EPS: JA$0.06 (vs JA$0.05 in 3Q 2022) Sep 16
Second quarter 2023 earnings released: EPS: JA$0.02 (vs JA$0.05 in 2Q 2022) Jun 14
Investor sentiment improves as stock rises 19% Jun 01
Upcoming dividend of JA$11.33 per share at 3.4% yield Apr 19
Investor sentiment improves as stock rises 26% Apr 01
First quarter 2023 earnings released: EPS: JA$0.04 (vs JA$0.04 in 1Q 2022) Mar 21
Investor sentiment improves as stock rises 17% Mar 01
Investor sentiment deteriorates as stock falls 22% Jan 30
Investor sentiment improved over the past week Dec 30
Investor sentiment improved over the past week Dec 08
Third quarter 2022 earnings released: EPS: JA$0.05 (vs JA$0.03 in 3Q 2021) Sep 15
Second quarter 2022 earnings released: EPS: JA$0.05 (vs JA$0.01 in 2Q 2021) Jun 15
Upcoming dividend of JA$0.11 per share Apr 28
Investor sentiment improved over the past week Jan 01
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Dec 18
Investor sentiment improved over the past week Dec 01
Third quarter 2021 earnings released: EPS JA$0.01 (vs JA$0.04 in 3Q 2020) Sep 15
Investor sentiment improved over the past week Jul 05
Second quarter 2021 earnings released: EPS JA$0.02 (vs JA$0.05 in 2Q 2020) Jun 18
Investor sentiment deteriorated over the past week May 20
Investor sentiment improved over the past week Apr 10
Investor sentiment improved over the past week Mar 23
First quarter 2021 earnings released: EPS JA$0.04 (vs JA$0.03 in 1Q 2020) Mar 17
Upcoming Dividend of JA$0.11 Per Share Feb 17
New 90-day high: JA$2.89 Feb 05
Full year 2020 earnings released: EPS JA$0.15 (vs JA$0.12 in FY 2019) Jan 31
Investor sentiment improved over the past week Jan 20
New 90-day low: JA$2.31 Jan 14
Full year 2020 earnings released: EPS JA$0.15 Dec 17
New 90-day low: JA$2.43 Nov 25
Indies Pharma Jamaica Limited Announces Appointment of Directors Oct 18
Third quarter earnings released Sep 13
CEO（最高経営責任者 Dr. Guna Sekhar Muppuri is Founder of Indies Pharma Jamaica Limited and serves as it's Executive Chairman, President and Chief Executive Officer. He is a Medical Doctor by profession and the Founder of th ... Show more
取締役 名称 ポジション 在職期間 報酬 所有権 Founder no data データなし データなし Co-Founder no data データなし 1.74% JMD 68.4m Non-Executive Independent Director 4.1yrs データなし 0.015% JMD 590.0k Non Executive Independent Director 4.1yrs データなし 0.050% JMD 1.9m Non-Executive Independent Director no data データなし 0.015% JMD 590.0k Non-Executive Independent Director 5.5yrs データなし データなし
もっと見る
経験豊富なボード: INDIESの 取締役会 は 経験豊富 であると考えられます ( 4.1年の平均在任期間)。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}